Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Tuesday, September 30

8:00 AM - 9:00 AM PT

Radiation and Cancer Physics 5: In Vivo Dosimetry and Treatment Verification
Speaker: Kang, Hyejoo, PhD - Loyola University Chicago, Maywood, IL
8:05 AM - 8:10 AM PT

1036 - Unveiling Cell Subsets and Molecular Characteristics Associated with Clinical Outcomes of Radiochemotherapy in Cervical Cancer at the Single-Cell Scale
Speaker: Lei, Tianyu - Renmin Hospital of Wuhan University, Wuhan, Hubei
8:05 AM - 8:10 AM PT

1042 - Automated CBCT-Based Tumor Volume Tracking is Prognostic in Virally-Mediated Head and Neck Cancer
Speaker: Stutheit-Zhao, Eric, MD, PhD - Princess Margaret Cancer Centre, Toronto, ON
8:05 AM - 8:10 AM PT

1048 - Adaptive vs. Non-Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC): Indirect Comparison of NRG-RTOG 0617 and 1106 Individual Patient Data
Speaker: Miccio, Joseph, MD - Yale School of Medicine, New Haven, CT
8:10 AM - 8:15 AM PT

1037 - Multi-omics Profiling Links Immunosuppressive Plasma Cells within Tertiary Lymphoid Structures to Clinical Survival in Cervical Cancer Patients Undergoing Chemoradiotherapy
Speaker: Huang, Qingyu, MD - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Jinan, Shandong, China, Jinan, Shandong
8:10 AM - 8:15 AM PT

1043 - Prognostic Implications of Detectable Postoperative Tumor Tissue-Modified HPV DNA in Patients with p16+ Oropharyngeal Squamous Cell Carcinoma Undergoing De-Intensified Adjuvant Radiation
Speaker: Riina, Matthew, MD - Hospital of the University of Pennsylvania, Philadelphia, PA
8:10 AM - 8:15 AM PT

1049 - Hypofractionated Intensity-Modulated Radiotherapy for Unresectable Non-Small Cell Lung Cancer: Preliminary Results of a Prospective Phase II Study
Speaker: Gao, Yuyan - The Department of Radiotherapy, Beijing Luhe Hospital,Capital Medical University, Beijing, China, Beijing, Beijing
8:10 AM - 8:20 AM PT

280 - Phase I Pre-Operative Single Fraction Dose Escalation Ablative Stereotactic Partial Breast Irradiation (S-PBI) Trial for Early Stage Breast Cancer
Speaker: Rahimi, Asal, MD, MS - University of Texas Southwestern Medical Center at Dallas, Dallas, TX
8:10 AM - 8:20 AM PT

285 - WF-1801: Cognitive Outcomes of a Single Arm Pilot Study of Ramipril for Prevention of Radiation-Induced Cognitive Decline in Glioblastoma Patients Receiving Chemoradiotherapy
Speaker: Goetz, Amanda, MD, MS - Atrium Health Wake Forest Baptist, Lexington, NC
8:10 AM - 8:20 AM PT

290 - Definitive Stereotactic Body Radiation Therapy for Resectable Non-Metastatic Pancreatic Ductal Adenocarcinoma: A Multi-Center Retrospective Analysis
Speaker: Chuong, Michael, MD - Miami Cancer Institute at Baptist Health South Florida, Miami, Florida
8:10 AM - 8:20 AM PT

295 - Development of a Robust FLASH Research Platform for In Vivo Spinal Cord Study with Image-Guided Dosimetry
Speaker: Zhou, Banghao, MS - UT Southwestern Medical Center, Dallas, TX
8:15 AM - 8:20 AM PT

1038 - Neutrophil Profiling Reveals Distinct Subsets in Predicting Chemoradiotherapy Efficacy in Cervical Cancer
Speaker: Wang, Qian, MD - Renmin Hospital of Wuhan University, Wuhan, Hubei